Skip Navigation



ToxSci Advance Access published online on April 15, 2003

Toxicological Sciences, doi:10.1093/toxsci/kfg074
Toxicological Sciences © Society of Toxicology 2003; all rights reserved
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
73/2/362    most recent
kfg074v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Hinton, D. M.
Right arrow Articles by Chou, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hinton, D. M.
Right arrow Articles by Chou, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Received November 26, 2002; accepted February 21, 2003
© 2003 Society of Toxicology

Immunotoxicology

Immunotoxicity of Aflatoxin B1 in Rats: Effects on Lymphocytes and the Inflammatory Response in a Chronic Intermittent Dosing Study

D. M. Hinton 1*, M. J. Myers 2, R. A. Raybourne 1, S. Francke-Carroll 1, R. E. Sotomayor 1, J. Shaddock 3, A. Warbritton 3, M. Chou 3

1 USFDA, CFSAN, Laurel, MD 20708
2 USFDA, CVM, Laurel, MD, 20708
3 USFDA, NCTR, Jefferson, AR., 72079

* To whom correspondence should be addressed. E-mail: dhinton{at}cfsan.fda.gov.


   Abstract

We investigated the effects of aflatoxin B1 (AFB1) on isolated splenic lymphocytes and the histo-morphologic changes in the spleens and liver and of Fisher-344 male rats. Weaned animals were fed chow diets that contained 0, 0.01, 0.04, 0.4 or 1.6 ppm AFB1, using an intermittent dosing regimen (4 weeks on and 4 weeks off AFB1), for 40 weeks. An additional group of animals was fed the 1.6 ppm AFB1 diet continuously. The intermittent dosing regimen was designed to evaluate effects of cumulative dose and exposure for risk assessment comparisons.

The percentages of T- and B-cells were affected as shown by flow cytometric analysis after the dosing cycles. The observed changes appeared to reverse or compensate to some extent after the off cycles. Lymphocytes were stimulated in culture for analysis of the production of IL-2, IL-1, and IL-6. Significantly increased production of IL-1 and IL-6 was seen in the 2nd dosing cycle (12 weeks) and the 2nd "off" cycle (16 weeks) at the higher doses. Inflammatory infiltrates were seen in the liver after 8 weeks of continuous and intermittent dosing and were increased in size and number at 12 weeks in both 1.6 ppm dose groups correlating with the peak production of Il-1 and IL-6. We concluded that AFB1 effects on the immune system can be either stimulatory or suppressive dependent on a critical exposure window of dose and time. Immune cells in spleen such as T-lymphocytes and macrophages, both important mediators of inflammatory responses to tissue damage, were affected differently in the continuous and intermittent exposures to AFB1.

Aflatoxin B1, Immunotoxicity, Inflammatory Response, Intermittent Dosing .


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Int ImmunolHome page
Y. Jiang, P. E. Jolly, W. O. Ellis, J.-S. Wang, T. D. Phillips, and J. H. Williams
Aflatoxin B1 albumin adduct levels and cellular immune status in Ghanaians
Int. Immunol., June 1, 2005; 17(6): 807 - 814.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.